4-Methyl-1,2,5-oxadiazole-3-carboxylic acid → N-[6-Chloro-2,4,8,18,22-pentaazatetracyclo[14.3.1.1(3,7).1(9,13)]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaen-12-yl]-2-{1-[(4-methyl-1,2,5-oxadiazol-3-yl)carbonyl]piperidin-4-yl}acetamide bis(trifluoroacetate)

Participants

Reaction Steps

The desired compound was prepared according to the procedure of Example A27, using N-[6-chloro-2,4,8,18,22-pentaazatetracyclo[14.3.1.1(3,7).1(9,13)]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaen-12-yl]-2-piperidin-4-ylacetamide bis(trifluoroacetate) and 4-methyl-1,2,5-oxadiazole-3-carboxylic acid as starting materials in 44% yield. LCMS for C28H29ClN9O3 (M+H)+: m/z=574.2.

Provenance & Evidence